Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 31, 2012

View Archived Issues

FANG cancer vaccine evaluated in phase I trial

JVRS-100 improves H5N1 vaccine immunogenicity

Novel muscarinic acetylcholine M1 receptor modulators disclosed

U.S. researchers prepare new vaccines

Novel protein kinase inhibitors disclosed by SBI Biotech and CrystalGenomics

NeuroSearch patents novel monoamine neurotransmitter reuptake inhibitors

Roche presents novel AMPK activators

University of Illinois forms new start-up company for cancer products

Medicure to commence SAVI-PCI trial of Aggrastat

Immune Pharmaceuticals granted funds by Israel's Office of the Chief Scientist

Study identifies potential biomarkers of Huntington's disease progression

Transcend-trastuzumab conjugate BT-2111 program advances

AMAG Pharmaceuticals completes enrollment in Feraheme trial

New antibodies designed by Novo Nordisk for hemophilia

Allos Therapeutics requests reexamination of CHMP opinion on Folotyn

FDA approves first treatment for advanced BCC

Health Canada accepts CIP-Isotretinoin submission for review

Jentadueto approved in U.S.

Servier and Monash University establish GPCR collaboration

Domain Therapeutics receives award to develop therapeutics for Parkinson's disease

Orexo ends collaboration with Janssen

Takeda returns Posidur rights to Durect

ATS-907 enters clinical development

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...